Clinical Topics & News
News
FDA approves cannabidiol for tuberous sclerosis complex
The agency approved the drug for patients 1 year of age and older.
News
FDA approves new treatment for Dravet syndrome
Children treated with fenfluramine experienced significantly greater reductions in the frequency of convulsive seizures than did their peers who...
News
Neurologists’ pay gets a boost, most happy with career choice
Neurologists’ average annual income this year rose to $280,000, up from $267,000 last year.
News
Are patients with epilepsy at increased risk of COVID-19 infection?
The COVID risk may not be elevated, but vigilance and caution are still warranted.
News
FDA approves diazepam nasal spray for seizure clusters
Valtoco may be administered by a care partner outside of a medical setting for the treatment of frequent seizure activity that is distinct from a...
News
FDA warns gabapentin, pregabalin may cause serious breathing problems
The drugs increase the risk of respiratory depression when used with central nervous system depressants or in patients with lung problems,...
Article
DEA Reclassifies Epidiolex as Schedule V
WASHINGTON, DC—The Drug Enforcement Administration (DEA) has reclassified Epidiolex, an oral cannabidiol (CBD) solution...
Clinical Topics & News
Status Epilepticus in Pregnancy
Article
FDA Approves a Cannabinoid Medicine for Two Forms of Epilepsy
The FDA has approved Epidiolex (...